Open Government Portal

Original Data

The European Medicines Agency completed a safety review of strontium ranelate, a drug available by prescription only in Europe at …

Record Modified: May 10, 2024
Record Released: May 8, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Strontium Risk Heart-and-Circulatory Side Effects osteoporosis risk of fracture strontium citrate strontium lactate strontium glucona
Similar Data

Learn about the health effects of strontium and how to reduce your exposure if it is present in your drinking …

Record Modified: Oct 7, 2020
Record Released: Oct 7, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Water Talk drinking water Strontium

This guideline technical document reviews and assesses all identified health risks associated with strontium in drinking water.

Record Modified: Sep 26, 2022
Record Released: Sep 26, 2022
Publisher: Health Canada
Formats: HTML
Keywords: water water quality drinking water quality potable water contaminants exposure to contaminants strontium in drinking-water

This dataset provides results obtained by Health Canada’s Canadian Radiological Monitoring Network (CRMN) for 90Sr activity in milk samples originating …

Record Modified: Mar 24, 2026
Record Released: Sep 24, 2016
Publisher: Natural Resources Canada
Formats: CSV ESRI REST WMS HTML TXT PPT
Keywords: environmental radioactivity monitoring analyse du lait radiation monitoring strontium-90 Health Radioactivity Radioactive materials

Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related …

Record Modified: May 8, 2024
Record Released: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Celecoxib safety review assessing heart-and-stroke side effects high doses Non-Steroidal Anti-Inflammatory Drugs NSAIDs diclofenac ibuprofen naproxen

A safety review was carried out by Health Canada to evaluate the increased risk of heart failure with the use …

Record Modified: May 8, 2024
Record Released: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Dipeptidylpeptidase-4 DPP-4 Inhibitors assessing risk heart failure saxagliptin alogliptin other risk factors